(Q36859184)

16 August 2017

Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer (English)

1 reference

16 August 2017

metastatic breast cancer

1 reference

1 reference

B Sherrill

1

1 reference

16 August 2017

M M Amonkar

2

1 reference

16 August 2017

S Stein

3

1 reference

16 August 2017

M Walker

4

1 reference

16 August 2017

C Geyer

5

1 reference

16 August 2017

D Cameron

6

1 reference

16 August 2017

language of work or name

English

0 references

publication date

19 August 2008

1 reference

British Journal of Cancer

16 August 2017

1 reference

16 August 2017

99

1 reference

16 August 2017

5

1 reference

16 August 2017

711-715

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604501

16 August 2017

0 references

cites work

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2528149

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2528149

Analyzing oncology clinical trial data using the Q-TWiST method: clinical importance and sources for health state preference data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2528149

Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2528149

Systematic overview of cost-utility assessments in oncology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2528149

EuroQol--a new facility for the measurement of health-related quality of life

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2528149

Quality adjusted survival analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2528149

A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2528149

Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2528149

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients. clinical outcomes and oncologists' preferences

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2528149

Nonparametric Estimation from Incomplete Observations

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604501

21 January 2018

Identifiers

DOI

10.1038/SJ.BJC.6604501

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

18728660

1 reference